Comparative study between Tokisyakuyakusan and mecobalamin for the efficacy in patients with olfactory dysfunction post-respiratory infection.
Not Applicable
- Conditions
- olfactory dysfunction
- Registration Number
- JPRN-UMIN000021006
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have rhinosinusitis which is subjected to effect on olfactory dysfunction post-respiratory infection. 2) Patients who used Tokisyakuyakusan or mecobalamin within the last two weeks (It will be eligible if they do not use those medicine for at least two weeks). 3) Patients who are pregnant, suspected to be pregnant or breastfeeding. 4) Patients who desire to bear children 5) Patients who are considered not to be eligible by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Tokisyakuyakusan's efficacy in post-viral olfactory dysfunction compared to mecobalamin?
How does Tokisyakuyakusan's therapeutic effect compare to mecobalamin in post-respiratory infection olfactory dysfunction patients?
Which biomarkers correlate with treatment response in JPRN-UMIN000021006 for olfactory dysfunction post-respiratory infection?
What are the safety profiles and adverse event management strategies for Tokisyakuyakusan versus mecobalamin in olfactory dysfunction trials?
Are there alternative vitamin B12 derivatives or herbal compounds with demonstrated efficacy for post-viral olfactory dysfunction in clinical studies?